32 results on '"Pina F"'
Search Results
2. P.298 - Pediatric onset of mitochondrial myopathy due to ANT1 mutation
3. HUMAN SERUM ANGIOPOIETIN-1 (ANG-1) LEVELS ARE NOT ASSOCIATED TO PATHOLOGY DIAGNOSIS ON PROSTATE BIOPSY
4. 205 TREATMENT OF MALE STRESS URINARY INCONTINENCE WITH THE BONE-ANCHORED PERINEAL SLING
5. TRANSFORMING GROWTH FACTOR-ALPHA (TGF-α) LEVEL IS ASSOCIATED WITH BOTH TO SERUM ANDROGEN AND PRIMARY ANDROGEN INSENSIBILITY PROSTATE CANCER (PCA) STATUS
6. SOLUBLE RECEPTOR OF HUMAN CYTOKINE IL-6 (SIL-6R) ON 123 PATIENTS WITH UNTREATED PROSTATE CANCER (PCA)
7. ADJUVANT THERAPY WITH BICALUTAMIDE 150 MG VERSUS STANDARD CARE ALONE: THIRD ANALYSIS RESULTS FROM TRIAL 24 OF THE EARLY PROSTATE CANCER PROGRAMME
8. Erratum to: Switching from intramolecular energy transfer to intramolecular electron transfer by the action of pH and Zn 2+ co-ordination [Chem. Phys. Lett. 353 (2002) 63–68]
9. 424 PROSTATE CANCER SCREENING: CAN IT BE IMPROVED WITH TOTAL TESTOSTERONE LEVELS?
10. 89 Influence of functional genetic variants of TGFβ1/TGFβR2 pathway in prostate cancer development.
11. 97 Non-synonym leptin receptor genetic variants, prostate cancer susceptibility and aggressiveness.
12. 7021 Leptin receptor genetic variants are associated with prostate cancer development, aggressiveness and the time to biochemical relapse.
13. Erratum to: Switching from intramolecular energy transfer to intramolecular electron transfer by the action of pH and Zn2+ co-ordination [Chem. Phys. Lett. 353 (2002) 63–68]
14. PO-221 HDR BRACHYTHERAPY BOOST AND EXTERNAL RADIOTHERAPY FOR UNFAVORABLE PROSTATE CANCER PATIENTS
15. UP-02.193 Soluble Circulating Receptor Endoglin (ENG) in Patients with Different Prostate Biopsy Diagnosis
16. UP-02.125 BMI and Bio-Impedance Factors Among Candidates to Prostate Cancer Screening: Implication of Obesity on Actual Cancer Diagnosis
17. POD-02.05 Temporal Trends in Prostate Cancer: A 50-Year Period Database Analysis
18. 380 Combined analysis of SNPs in IL-6/IL-6R pathway predict prostate cancer aggressiveness and development of resistance to hormonal castration.
19. 96 Adiponectin functional polymorphisms and haplotype are associated with prostate cancer aggressiveness and to hormonal castration resistance.
20. MP-21.08: Association between IGF-I and Prostatitis, PIN III and Prostate Cancer Diagnosis
21. MP-21.07: Human Serum Angiogenin (ANG-0) Increases with More Aggressive Prostate Pathology
22. 7023 Osteopontin functional genetic polymorphism is associated with prostate cancer biochemical recurrence and androgen independence.
23. 7022 Genetic profile of IL-6/IL6R pathway predicts susceptibility, agressiveness and response to hormonal treatment in prostate cancer patients.
24. 1101 Prostate cancer and apoptosis: An insight of FAS-670A/G polymorphism role in tumor development.
25. Proliferative/Angiogenic genetic profile is associated with progression-free-interval in androgen blockade treated prostate cancer patients.
26. Interleukin-6 functional polymorphism influences susceptibility and has a predictive factor in prostate cancer patients receiving androgen blockade therapy.
27. 727 HUMAN SERUM ANGIOPOIETIN-1 (ANG-1) LEVELS ARE NOT ASSOCIATED TO PATHOLOGY DIAGNOSIS ON PROSTATE BIOPSY
28. Electrochromism of Crystal Violet Lactone in the presence of Fe(III)/Fe(II) redox pair
29. 1092 poster GASTRIC CANCER TREATMENT: THE EXPERIENCE OF
30. Hospital Resource Utilization and Treatment Cost of Skeletal-Related Events in Patients with Metastatic Breast or Prostate Cancer: Estimation for the Portuguese National Health System
31. Solid-state electrochromic devices using pTMC/PEO blends as polymer electrolytes
32. POD-1.04: The bone-anchored perineal male sling for post-prostatectomy incontinence: results up to 5 years of follow-up
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.